Chiron Selects Former Glaxo Wellcome Topsider Lance To Lead Biotech Firm
This article was originally published in The Gray Sheet
Executive Summary
Although incoming Chiron Chief Executive Officer Sean Lance lacks experience in both the diagnostics business and the U.S. market, the company is suggesting a parallel between Glaxo Wellcome's growth during his tenure as chief operating officer and Chiron's future as a maturing biotechnology concern.